BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7478568)

  • 1. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F.
    Ormondroyd E; de la Luna S; La Thangue NB
    Oncogene; 1995 Oct; 11(8):1437-46. PubMed ID: 7478568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proto-oncogenic properties of the DP family of proteins.
    Jooss K; Lam EW; Bybee A; Girling R; Müller R; La Thangue NB
    Oncogene; 1995 Apr; 10(8):1529-36. PubMed ID: 7731707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and functional characterisation of E2F-5, a new member of the E2F family.
    Buck V; Allen KE; Sørensen T; Bybee A; Hijmans EM; Voorhoeve PM; Bernards R; La Thangue NB
    Oncogene; 1995 Jul; 11(1):31-8. PubMed ID: 7542760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new component of the transcription factor DRTF1/E2F.
    Girling R; Partridge JF; Bandara LR; Burden N; Totty NF; Hsuan JJ; La Thangue NB
    Nature; 1993 Mar; 362(6415):83-7. PubMed ID: 8446173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characterization and specificity of expression of E2F-5: a new member of the E2F family of transcription factors.
    Itoh A; Levinson SF; Morita T; Kourembanas S; Brody JS; Mitsialis SA
    Cell Mol Biol Res; 1995; 41(3):147-54. PubMed ID: 8589754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of a chicken homolog of the E2F-1 transcription factor.
    Pasteau S; Loiseau L; Arnaud L; Trembleau A; Brun G
    Oncogene; 1995 Oct; 11(8):1475-86. PubMed ID: 7478572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.
    de la Luna S; Allen KE; Mason SL; La Thangue NB
    EMBO J; 1999 Jan; 18(1):212-28. PubMed ID: 9878064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.
    Cartwright P; Müller H; Wagener C; Holm K; Helin K
    Oncogene; 1998 Aug; 17(5):611-23. PubMed ID: 9704927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
    Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
    Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer.
    Suzuki M; Okuyama S; Okamoto S; Shirasuna K; Nakajima T; Hachiya T; Nojima H; Sekiya S; Oda K
    Oncogene; 1998 Aug; 17(7):853-65. PubMed ID: 9780002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis.
    Shan B; Farmer AA; Lee WH
    Cell Growth Differ; 1996 Jun; 7(6):689-97. PubMed ID: 8780882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic structure and developmental expression of the mouse cell cycle regulatory transcription factor DP1.
    Gopalkrishnan RV; Dollé P; Mattei MG; La Thangue NB; Kedinger C
    Oncogene; 1996 Dec; 13(12):2671-80. PubMed ID: 9000141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
    Good L; Dimri GP; Campisi J; Chen KY
    J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. dE2F2, a novel E2F-family transcription factor in Drosophila melanogaster.
    Sawado T; Yamaguchi M; Nishimoto Y; Ohno K; Sakaguchi K; Matsukage A
    Biochem Biophys Res Commun; 1998 Oct; 251(2):409-15. PubMed ID: 9792788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of human DP2, a novel dimerization partner of E2F.
    Zhang Y; Chellappan SP
    Oncogene; 1995 Jun; 10(11):2085-93. PubMed ID: 7784053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.